240 related articles for article (PubMed ID: 5354514)
41. Chemotherapy in polycythemia vera.
Stecher G; Reinhardt G
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):292-302. PubMed ID: 5241850
[No Abstract] [Full Text] [Related]
42. The management of polycythaemia vera.
Wasserman LR
Br J Haematol; 1971 Oct; 21(4):371-6. PubMed ID: 4941523
[No Abstract] [Full Text] [Related]
43. [Polycythemia vera].
Takaku F
Naika; 1970 Jun; 25(6):1229-30. PubMed ID: 5431275
[No Abstract] [Full Text] [Related]
44. The treatment of polycythemia vera.
Wasserman LR
Semin Hematol; 1976 Jan; 13(1):57-78. PubMed ID: 1251223
[No Abstract] [Full Text] [Related]
45. [Treatment of polyglobulias].
FAUVERT R; BOIVIN P
Cah Coll Med Hop Paris; 1963 Mar; 4():262-8. PubMed ID: 13944559
[No Abstract] [Full Text] [Related]
46. Current management of polycythemia vera and related diseases.
Laszlo J
Postgrad Med; 1974 May; 55(5):168-73. PubMed ID: 4596317
[No Abstract] [Full Text] [Related]
47. Chromosomal aberrations in polycythemia vera.
Modan B; Padeh B; Kallner H; Akstein E; Meytes D; Czerniak P; Ramot B; Pinkhas J; Modan M
Blood; 1970 Jan; 35(1):28-38. PubMed ID: 5412672
[No Abstract] [Full Text] [Related]
48. [Treatment of primary polyglobulism (Vaquez' disease)].
BOIVIN P; MALLARME J; FAUVERT R
Rev Prat; 1962 Sep; 12():2389-97. PubMed ID: 13968556
[No Abstract] [Full Text] [Related]
49. [Chemotherapy of patients with erythremia].
Ianovskiĭ DN; Chepeleva MA
Vrach Delo; 1969 Apr; 4():20-4. PubMed ID: 5373585
[No Abstract] [Full Text] [Related]
50. Survival of patients with polycythemia vera on busulfan or 32P.
Mathé G
N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270
[No Abstract] [Full Text] [Related]
51. Major surgery in patients with polycythaemia vera.
Rudowski W; Klawe Z; Woźniewska M; Ziemski JM
Haematologia (Budap); 1974; 8(1-4):477-83. PubMed ID: 4461433
[No Abstract] [Full Text] [Related]
52. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
Penttilä O; Ikkala E
Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
[No Abstract] [Full Text] [Related]
53. Polycythemia vera in dogs.
McGrath CJ
J Am Vet Med Assoc; 1974 Jun; 164(11):1117-22. PubMed ID: 4857967
[No Abstract] [Full Text] [Related]
54. [Clinical and therapeutic aspects of polycythemia vera].
Corneo G; Galli C; Airoldi M; Ceccherini Nelli L
Recenti Prog Med; 1978 Jun; 64(6):701-19. PubMed ID: 746241
[No Abstract] [Full Text] [Related]
55. THE USE OF FERROKINETICS IN THE EVALUATION OF BUSULPHAN THERAPY IN POLYCYTHAEMIA VERA.
BRODSKY I
Br J Haematol; 1964 Jul; 10():291-8. PubMed ID: 14179484
[No Abstract] [Full Text] [Related]
56. [Treatment of erythremia with imifos (10-year experience with hospital and ambulatory treatment of patients)].
Demidova AV; Shcherbak EM; Kozlova AF
Ter Arkh; 1975; 47(1):56-62. PubMed ID: 1114449
[No Abstract] [Full Text] [Related]
57. [Therapy of lymphogranuloma].
Hennemann HH
Minerva Med; 1970 May; 61(38):2097-9. PubMed ID: 5420339
[No Abstract] [Full Text] [Related]
58. [Polycythemia vera. Clinical course, diagnosis and therapy].
Braumann D; Mainzer K
Dtsch Med Wochenschr; 1983 Oct; 108(40):1524-9. PubMed ID: 6617509
[No Abstract] [Full Text] [Related]
59. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
60. Treatment and prognosis of polycythaemia managed by non-radioactive methods.
Israëls MC
Proc R Soc Med; 1966 Nov; 59(11 Part 1):1100-2. PubMed ID: 5954250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
